The price of zanubrutinib varies due to differences in specifications, regions and medical insurance policies. In the domestic Chinese market, it gene···【Read More】
Update: 2026-02-05Source: Haiou HealthViews: 77
The price of zanubrutinib varies due to factors such as drug specifications, regions, and medical insurance policies. It generally ranges from USD 865···【Read More】
Update: 2026-02-05Source: Haiou HealthViews: 75
During treatment with zanubrutinib, strict adherence to dietary restrictions is required to prevent compromised drug efficacy or elevated side effect ···【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 73
On June 30, 2025, vebreltinib enteric-coated capsules (brand name: Wanbirui, vebreltinib), a MET inhibitor independently developed by Beijing Purinno ···【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 73
On April 23, 2024, the National Medical Products Administration (NMPA) of China formally approved Vebreltinib Enteric-coated Capsules (brand name: Wan···【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 73
On November 16, 2023, the National Medical Products Administration (NMPA) released an announcement approving Vebreltinib Enteric-Coated Capsules (trad···【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 73
Vebreltinib is a prescription drug. Unauthorized personal mailing of this medication violates pharmaceutical regulatory requirements and express deliv···【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 72
It is usually administered orally once daily. Dosage adjustments must be made strictly under the guidance of a physician.【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 72
Vebreltinib is indicated for adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) confirmed by testing to carry MET e···【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 81
Vebreltinib is an oral small-molecule tyrosine kinase inhibitor, primarily used for the treatment of patients with advanced or metastatic non-small ce···【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 73
Vebreltinib is a targeted therapeutic drug indicated for specific gene mutations (e.g., MET exon14 skipping mutation), primarily used for indications ···【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 71
Vebreltinib (Wanbirui) is a prescription drug and can only be purchased with a doctor’s prescription. The primary purchasing channels are the pharmacy···【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 72
The monthly cost of vebreltinib generally varies depending on factors such as the patient’s region, prescribed dosage, and medical insurance policies,···【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 73
The reference price range for Vebreltinib Enteric-Coated Capsules is approximately US$$865 to U$$1,730 per box (30-capsule pack). The exact cost varie···【Read More】
Update: 2026-02-04Source: Haiou HealthViews: 79
vebreltinib is an oral tyrosine kinase inhibitor (TKI) primarily indicated for the treatment of non-small cell lung cancer (NSCLC) harboring specific ···【Read More】
Update: 2026-02-03Source: Haiou HealthViews: 72
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



